Table 1.
Estimates of anti-HCV prevalence and incidence by geographic region.
| Geographic region | Prevalence | Incidence | ||||
|---|---|---|---|---|---|---|
| Record | Participant | Pooled prevalence estimates, % (95% CI) | Record | Follow up person year | Pooled incidence estimates, /1,000 py (95% CI) | |
| Asia | 46 | 307,980 | 4.6 (3.8–5.5) | 7 | 34,650 | 6.4 (2.0–13.0) |
| Eastern Asia | 33 | 298,609 | 1.9 (1.6–2.3) | 6 | 30,638 | 5.5 (1.0–13.3) |
| China | 20 | 284,596 | 1.2 (1.0–1.5) | 1 | 507 | 2.0 (0.0–8.5) |
| Hong Kong SAR | 1 | 6,295 | 2.2 (1.2–3.6) | |||
| Japan | 1 | 1,068 | 2.1 (1.3–3.0) | 1 | 2,246 | 9.4 (5.7–13.8) |
| Mongolia | 1 | 50 | 36.0 (23.2–49.9) | |||
| South Korea | 1 | 320 | 4.1 (2.1–6.5) | 1 | 1,550 | 2.6 (0.6–5.9) |
| Taiwan Province | 10 | 12,575 | 3.2 (2.1–4.4) | 2 | 20,040 | 9.7 (0.5–30.0) |
| South-Eastern Asia | 8 | 2,406 | 29.0 (14.4–46.1) | 1 | 4,012 | 12.5 (9.2–16.1) |
| Indonesia | 1 | 77 | 32.5 (22.4–43.4) | |||
| Malaysia | 1 | 179 | 59.2 (51.9–66.3) | |||
| Myanmar | 1 | 177 | 3.4 (1.1–6.7) | |||
| Singapore | 1 | 4,012 | 12.5 (9.2–16.1) | |||
| Thailand | 2 | 108 | 41.4 (4.6–85.3) | |||
| Vietnam | 3 | 1,865 | 22.6 (4.9–47.8) | |||
| Southern Asia | 3 | 5,514 | 15.1 (0.3–44.5) | |||
| Afghanistan | 1 | 124 | 30.6 (22.8–39.1) | |||
| India | 1 | 4,994 | 1.3 (1.0–1.6) | |||
| Pakistan | 1 | 396 | 23.5 (19.4–27.8) | |||
| Western Asia | 2 | 1,451 | 1.3 (0.0–4.6) | |||
| Lebanon | 1 | 1,351 | 0.7 (0.3–1.3) | |||
| Turkey | 1 | 100 | 3.0 (0.4–7.5) | |||
| Europe | 84 | 86,525 | 5.3 (3.8–6.9) | 26* | 269,160 | 8.9 (7.0–11.1) |
| Eastern Europe | 2 | 441 | 4.5 (0.9–10.1) | |||
| Moldova | 1 | 391 | 3.3 (1.7–5.4) | |||
| Russia | 1 | 50 | 8.0 (1.8–17.4) | |||
| Northern Europe | 26 | 25,999 | 5.1 (1.6–10.1) | 4 | 89,721 | 7.6 (6.1–9.3) |
| Denmark | 2 | 397 | 1.5 (0.5–3.0) | 1 | 3,484 | 4.0 (2.2–6.4) |
| Estonia | 1 | 43 | 4.7 (0.1–13.5) | |||
| Sweden | 3 | 1,326 | 4.9 (0.0–16.2) | |||
| United Kingdom | 20 | 24,233 | 5.6 (1.6–11.7) | 3 | 86,237 | 8.5 (7.9–9.1) |
| Southern Europe | 21 | 8,934 | 6.4 (4.6–8.6) | 5 | 14,001 | 7.5 (4.0–11.9) |
| Croatia | 2 | 565 | 2.6 (1.4–4.2) | |||
| Greece | 1 | 124 | 8.1 (3.8–13.6) | |||
| Italy | 7 | 1,826 | 8.1 (4.8–12.2) | 2 | 4,700 | 7.2 (0.7–19.5) |
| Spain | 11 | 6,419 | 6.3 (3.7–9.4) | 3 | 9,301 | 8.4 (3.2–16.0) |
| Western Europe | 35 | 51,151 | 4.7 (3.6–5.9) | 16 | 146,510 | 10.2 (7.1–13.9) |
| Austria | 1 | 823 | 3.0 (2.0–4.3) | 1 | 4,892 | 7.4 (5.1–10.0) |
| Belgium | 3 | 641 | 3.9 (0.9–8.8) | 1 | 318 | 28.3 (12.5–49.8) |
| France | 8 | 15,783 | 4.2 (2.1–7.0) | 4 | 59,728 | 7.4 (4.8–10.5) |
| Germany | 5 | 8,731 | 9.7 (3.3–19.0) | 1 | 6,054 | 16.4 (13.3–19.7) |
| Netherlands | 9 | 8,311 | 4.9 (2.5–8.0) | 8 | 51,811 | 11.5 (5.1–20.5) |
| Switzerland | 9 | 16,862 | 3.2 (2.0–4.6) | 1 | 23,707 | 4.3 (3.5–5.1) |
| Africa | 13 | 5,557 | 4.3 (2.3–6.9) | |||
| Eastern Africa | 3 | 1,427 | 9.6 (3.7–17.8) | |||
| Tanzania | 3 | 1,427 | 9.6 (3.7–17.8) | |||
| Northern Africa | 1 | 224 | 8.5 (5.2–12.5) | |||
| Libya | 1 | 224 | 8.5 (5.2–12.5) | |||
| Southern Africa | 3 | 1,572 | 3.4 (2.1–5.1) | |||
| South Africa | 3 | 1,572 | 3.4 (2.1–5.1) | |||
| Western Africa | 6 | 2,334 | 2.2 (0.5–5.0) | |||
| Burkina Faso | 2 | 512 | 5.0 (0.0–18.6) | |||
| Cote d'Ivoire | 1 | 206 | 1.0 (0.0–2.9) | |||
| Mali | 1 | 320 | 0.6 (0.0–1.9) | |||
| Nigeria | 1 | 1,125 | 3.1 (2.2–4.2) | |||
| Togo | 1 | 171 | 0.6 (0.0–2.5) | |||
| Northern America | 33 | 33,067 | 7.8 (5.9–9.9) | 10 | 371,436 | 7.4 (5.3–9.9) |
| Canada | 9 | 5,618 | 9.1 (4.5–15.0) | 3 | 11,269 | 4.5 (3.3–5.9) |
| United States | 24 | 27,449 | 7.3 (5.3–9.7) | 7 | 360,167 | 8.3 (5.6–11.5) |
| Latin | ||||||
| America/Caribbean | 15 | 6,890 | 8.7 (4.1–14.8) | |||
| Caribbean | 2 | 1,429 | 2.7 (1.9–3.7) | |||
| Dominican Republic | 1 | 1,388 | 3.2 (2.3–4.2) | |||
| Puerto Rico | 1 | 41 | 4.9 (0.1–14.1) | |||
| Central America | 2 | 177 | 63.5 (0.0–100.0) | |||
| Mexico | 2 | 177 | 63.5 (0.0–100.0) | |||
| South America | 11 | 5,284 | 4.1 (2.3–6.3) | |||
| Argentina | 6 | 2,668 | 6.5 (3.2–10.9) | |||
| Brazil | 3 | 1,117 | 0.8 (0.3–1.5) | |||
| Colombia | 1 | 1,100 | 2.1 (1.3–3.0) | |||
| Peru | 1 | 399 | 3.8 (2.1–5.9) | |||
| Oceania | 5 | 5,864 | 7.6 (3.6–12.8) | 6 | 29,033 | 11.8 (5.3–21.0) |
| Australia | 5 | 5,864 | 7.6 (3.6–12.8) | 6 | 29,033 | 11.8 (5.3–21.0) |
| Global | 196 | 445,883 | 5.9 (5.1–6.8) | 49 | 704,249 | 8.6 (7.2–10.0) |
*
There is a multi-center incidence study conduct in the whole Europe.
HCV, hepatitis C virus; CI, confidence interval.
Bold values represent results at the global or regional level, and non-bold values represent results at national level.